Advertisement

Topics

Unum Therapeutics: IND Application Active For ACTR087 With SEA-BCMA

08:17 EDT 23 Aug 2017 | RTTNews

Unum Therapeutics Inc., a clinical stage biopharmaceutical company developing a universal cellular immunotherapy to treat multiple cancers, said that an investigational new drug or IND application is now active for ACTR087 T cells in combination with a novel antibody, SEA-BCMA, for the treatment of adult patients with relapsed/refractory multiple myeloma.

Original Article: Unum Therapeutics: IND Application Active For ACTR087 With SEA-BCMA

NEXT ARTICLE

More From BioPortfolio on "Unum Therapeutics: IND Application Active For ACTR087 With SEA-BCMA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...